financetom
Business
financetom
/
Business
/
Indonesia discussing plan for merger of Grab and GoTo, official says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Indonesia discussing plan for merger of Grab and GoTo, official says
Nov 7, 2025 5:48 AM

JAKARTA, Nov 7 (Reuters) - Indonesia is discussing a

possible merger or acquisition between ride-hailing and food

delivery firm Grab and its rival GoTo, the

presidential spokesperson said on Friday.

The government considers the ride-hailing industry as

strategic for job creation and vital to the economy. GoTo's

Gojek unit alone has more than 3.1 million online riders, and

GoTo and Grab have dominated the Indonesian market for years.

A combined entity would hold a market share of over 91% in

Indonesia, according to data analytics company, Euromonitor

International.

Indonesian government spokesperson Prasetyo Hadi said a

decision would come soon.

"Online riders are economic heroes, driving the economy," he

said.

Grab and GoTo did not immediately respond to request for

comments.

Reuters has previously reported that Nasdaq-listed Grab was

looking to strike a deal to buy smaller rival GoTo in the second

quarter this year and had hired advisers to work on the proposed

acquisition. A deal could value GoTo at around $7 billion, a

source close to the matter said earlier this year.

GoTo is 73.90%-owned by foreign investors, including

SoftBank Group and Taobao China Holding, a unit of

China's Alibaba Group, with the rest owned by

Indonesian investors, according to its 2024 annual report.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nestle, others warn EU law delays are endangering forests worldwide  
Nestle, others warn EU law delays are endangering forests worldwide  
Oct 3, 2025
* Nestle, Ferrero warn EU against further delays to deforestation law * Law aims to curb global deforestation linked to EU consumption * EU says delay necessary to address concerns about IT readiness By Virginia Furness LONDON, Oct 3 (Reuters) - Major agri-food companies including Nestle, Ferrero and Olam Agri have warned that European Union delays to its anti-deforestation law...
Hesai Group Reaches One Million Mark in Lidar Annual Production in 2025
Hesai Group Reaches One Million Mark in Lidar Annual Production in 2025
Oct 3, 2025
08:38 AM EDT, 10/03/2025 (MT Newswires) -- Hesai Group ( HSAI ) said Friday that it has produced its one-millionth lidar unit this year, becoming the first lidar company to achieve that milestone in annual production. The company said that as of Q2, it had delivered more than 1.4 million lidar units cumulatively across the robotics and advanced driver assistance...
Quantum Biopharma Set Oct. 27 as Record Date For CVRs Distribution Tied to Future Settlement Proceeds
Quantum Biopharma Set Oct. 27 as Record Date For CVRs Distribution Tied to Future Settlement Proceeds
Oct 3, 2025
08:45 AM EDT, 10/03/2025 (MT Newswires) -- Quantum BioPharma ( QNTM ) said Friday it has established Oct. 27, as the record date for the distribution of contingent value rights (CVRs) on a one-to-one basis to holders of its class B subordinate voting shares. The source of any potential payment will be linked to payouts to a US$700 million lawsuit...
Esperion Therapeutics Settles Patent Lawsuit Against Dr. Reddy's Laboratories Over Cholesterol Drugs
Esperion Therapeutics Settles Patent Lawsuit Against Dr. Reddy's Laboratories Over Cholesterol Drugs
Oct 3, 2025
08:44 AM EDT, 10/03/2025 (MT Newswires) -- Esperion Therapeutics ( ESPR ) said Friday that it has agreed to settle a patent lawsuit against Dr. Reddy's Laboratories (RDY) related to its cholesterol drugs Nexletol and Nexlizet. Under the terms of the settlement, Dr. Reddy's Laboratories has agreed not to market a generic version of either Nexletol or Nexlizet in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved